Coherus Oncology, Inc. Common Stock
CHRS
CHRS
186 hedge funds and large institutions have $1.21B invested in Coherus Oncology, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
-2
Holders Change %
-1.06%
% of All Funds
4.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
73
Reduced
62
Closed
28
Calls
$3.88M
Puts
$3.45M
Net Calls
+$434K
Net Calls Change
-$3.65M
Top Buyers
1 |
CCM
Consonance Capital Management
New York
|
$32.8M |
2 |
Ameriprise
Minneapolis,
Minnesota
|
$55.8M |
3 |
AllianceBernstein
Nashville,
Tennessee
|
$52.3M |
4 |
![]()
JPMorgan Chase & Co
New York
|
$66.9M |
5 |
Invesco
Atlanta,
Georgia
|
$14.7M |